This study states that The administration of type II endoleak (T2E) stays dubious due to the heterogeneous result. For blood-based screening to identify dangerous T2E, we zeroed in on platelets after endovascular aneurysm fix (EVAR) and contrasted them and the forecast of T2Es. 

From 2007 to 2015, there were 249 patients treated with EVAR for stomach aortic aneurysm who were assessed reflectively. The mean subsequent period was 3.5 ± 0.2 years. T2Es that had aneurysm sac growth or changed over to type I or type III endoleak were characterized as dangerous; the other T2Es were considered generous. Cases with no inconveniences, including T2E, were characterized as finished. We looked at the platelet rely on postoperative days (PODs) 1 to 7 with preoperative standard qualities among the three gatherings. Consecutively, we determined the cutoff of the platelet proportion on POD 7 to the gauge esteem according to dangerous T2E utilizing collector working trademark examination, and the cutoff proportion was 113%. 

Reference link-